Can Prostate Cancer Grow Slowly Without Symptoms?

Prostate cancer often does grow slowly and can remain entirely without symptoms for years, particularly lower grade disease. This is exactly why screening matters, symptoms such as urinary difficulty, blood in urine or bone pain typically appear only once disease has become locally advanced or spread. But this is not universal. Higher grade tumours can progress far more aggressively, and how a particular cancer will behave is determined by its grade, not assumed from the diagnosis itself.

According to Dr. Sandeep Nayak, Surgical Oncologist in India, “Prostate cancer has earned a reputation for being slow moving, and for many men that reputation is accurate, particularly with lower grade disease detected early. But I am careful never to let that reputation create complacency. A higher grade tumour behaves very differently and can progress quickly. The Gleason score tells us which situation we are dealing with. That number, not the general reputation of the disease, is what should guide the conversation about treatment or surveillance.”

Understanding why symptoms are frequently absent clarifies why screening remains important.

• Slow cellular growth : Many prostate cancers, particularly lower grade ones, divide slowly, which is why disease can be present for years before it produces any symptoms.
• Location within the gland : Tumours confined within the prostate often do not press on surrounding structures early enough to cause noticeable symptoms.
• Symptoms appear later : Urinary changes, blood in urine or bone pain generally reflect disease that has grown locally advanced or already spread.
• Screening fills the gap : PSA testing and digital rectal exam are designed specifically to detect disease before symptoms would otherwise prompt an evaluation.

Recognising this pattern underpins effective prostate cancer treatment planning, since asymptomatic disease still requires an accurate assessment of its behaviour.

The slow growing reputation of prostate cancer does not apply uniformly to every case.

• Grade determines behaviour : The Gleason score and grade group classify how aggressive a tumour’s cells appear, and this, not the diagnosis alone, predicts its likely course.
• Higher grade disease progresses faster : Aggressive tumours can grow and spread considerably more quickly than the slow growing pattern often associated with prostate cancer generally.
• Active surveillance applies selectively : Monitoring rather than immediate treatment is a legitimate option specifically for confirmed low risk, slow growing disease, not for every diagnosis.
• Individual assessment matters : Treating every prostate cancer as equally indolent risks underestimating disease that genuinely requires prompt treatment.

Understanding this distinction is central to the broader picture covered in our guide on early detection of prostate cancer, where identifying disease early allows this grading to happen sooner.

Dr. Sandeep Nayak is a surgical oncologist with 24 years of experience and a fellowship in laparoscopic and robotic onco-surgery. His approach to prostate cancer prioritises accurate grading before deciding between active surveillance and treatment, recognising that a diagnosis alone does not indicate how a particular cancer will behave. This means basing decisions on the specific tumour’s grade rather than general assumptions about the disease.

The reassuring reputation of prostate cancer as slow growing holds true often enough to matter, but treating it as a universal rule risks missing the cases that do not fit it. Grading each tumour accurately, and matching the response, surveillance for genuinely low risk disease, treatment for anything more aggressive, is what allows this reputation to be used constructively rather than as an excuse for complacency.

References

1. Natural history and grading of prostate cancer — National Library of Medicine
2. Active surveillance outcomes in low risk prostate cancer — National Library of Medicine

Disclaimer: This blog is for informational and educational purposes only and is not a substitute for professional medical advice or diagnosis.